Altamira Therapeutics Ltd. (CYTO)

NASDAQ: CYTO · IEX Real-Time Price · USD

1.600

+0.160 (11.11%)

At close: Apr 25, 2024, 4:00 PM

1.560

-0.040 (-2.50%)

Pre-market: Apr 26, 2024, 4:32 AM EDT

Altamira Therapeutics Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Equivalents	0.62	0.02	0.98	11.26	1.38	5.39	14.97	32.44	50.24	56.93	Upgrade
Short-Term Investments	0	0	0	0	0	0	0	0	0	0.54	Upgrade
Cash & Cash Equivalents	0.62	0.02	0.98	11.26	1.38	5.39	14.97	32.44	50.24	57.48	Upgrade
Cash Growth	3910.45%	-98.44%	-91.26%	713.08%	-74.32%	-63.98%	-53.85%	-35.42%	-12.60%	140.84%	Upgrade
Receivables	0.07	0.76	0.69	0.08	0.36	0.34	0.32	0.41	0.69	0.54	Upgrade
Inventory	0	0.01	0.84	0	0	0	0	0	0	0	Upgrade
Other Current Assets	0.53	0.98	1.58	0.28	0.63	0.34	0.58	0.84	0.14	-0.28	Upgrade
Total Current Assets	1.22	1.77	4.09	11.62	2.37	6.06	15.87	33.69	51.07	57.74	Upgrade
Property, Plant & Equipment	0.08	0.45	0.56	0.05	0.07	0.03	0.25	0.37	0.22	0.24	Upgrade
Long-Term Investments	2.42	0	0	0	0	0	0	0	0	0	Upgrade
Goodwill and Intangibles	3.89	3.89	14.31	9.12	6.77	3.54	1.63	1.48	1.48	1.48	Upgrade
Other Long-Term Assets	0.08	0.19	0.2	0.02	0.02	0.24	0.08	0.11	0.04	0.03	Upgrade
Total Long-Term Assets	6.47	4.53	15.08	9.18	6.85	3.81	1.96	1.97	1.74	1.75	Upgrade
Total Assets	7.69	6.3	19.17	20.8	9.23	9.88	17.83	35.66	52.81	59.49	Upgrade
Accounts Payable	0.44	4.91	3.7	0.76	0.94	1.84	1.2	1.84	1.21	3.23	Upgrade
Deferred Revenue	0	0.93	0	0	0	0	0	0	0	0	Upgrade
Current Debt	0.1	5.99	0.11	0.52	0	1.44	4.54	2.21	0	0	Upgrade
Other Current Liabilities	0.35	1.05	1.05	1.74	1.34	1.29	4.68	4.91	4.96	1.2	Upgrade
Total Current Liabilities	0.89	12.88	4.86	3.03	2.28	4.56	10.43	8.96	6.17	4.44	Upgrade
Long-Term Debt	0	0.34	0.46	0	0	0	5.58	10.15	0	0	Upgrade
Other Long-Term Liabilities	0.35	1.39	0.81	1	0.91	1.66	3.98	2.41	1.9	1.77	Upgrade
Total Long-Term Liabilities	0.35	1.74	1.27	1	0.91	1.66	9.56	12.56	1.9	1.77	Upgrade
Total Liabilities	1.24	14.62	6.13	4.03	3.19	6.23	19.99	21.52	8.07	6.21	Upgrade
Total Debt	0.1	6.33	0.58	0.52	0	1.44	10.13	12.36	0	0	Upgrade
Debt Growth	-98.43%	999.68%	9.89%	-	-	-85.83%	-18.10%	-	-	-	Upgrade
Retained Earnings	-18.05	-201.43	-175.69	-160.64	-152.78	-146.3	-136.13	-112.34	-81.58	-52.13	Upgrade
Comprehensive Income	0	0	0.06	0.06	-0.03	-0.04	-0.03	-0.08	-0.06	-0.05	Upgrade
Shareholders' Equity	6.46	-8.31	13.04	16.77	6.04	3.65	-2.16	14.14	44.74	53.28	Upgrade
Net Cash / Debt	0.52	-6.32	0.41	10.73	1.38	3.96	4.85	20.08	50.24	57.48	Upgrade
Net Cash / Debt Growth	-	-	-96.20%	675.24%	-65.01%	-18.34%	-75.86%	-60.03%	-12.60%	466.02%	Upgrade
Net Cash Per Share	-	-	-	-	-	-	-	-	124349.75	166119.44	Upgrade
Working Capital	0.33	-11.11	-0.77	8.59	0.1	1.5	5.44	24.73	44.9	53.3	Upgrade
Book Value Per Share	16.24	-194.91	382.21	1325.92	1287.85	6035.73	-5038.69	32982.47	110818.63	153927.11	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).